This addendum addresses the safety of Hexyl Salicylate, focusing specifically on exposure and safety for children aged 0–3 years. Hexyl Salicylate is a chemical commonly used in cosmetic products and other consumer goods.
1. Chemical and Physical Specifications:
Includes information on substance codes, impurities, and composition.
Covers solubility, partition coefficient, and additional specifications.
2. Exposure Assessment and Toxicokinetics:
Assesses the role of Hexyl Salicylate in products and its usage.
Reviews studies on how the chemical is absorbed through the skin.
Includes calculations of Systemic Exposure Dose (SED) and Local Exposure Dose (LED).
3. Toxicological Evaluation:
Evaluates potential irritation and corrosive effects.
Assesses the potential for causing allergic reactions.
Covers short-term and long-term toxicity.
Examines potential effects on reproduction.
Investigates potential hormonal disruptions.
Looks at genetic and mutagenic effects.
Assesses cancer risk.
Evaluates potential toxicity when exposed to light.
Includes any available data on human exposure and special studies.
4. Safety Evaluation:
Calculation of the safety margin based on the available data.
Provides an overall assessment of the safety of Hexyl Salicylate.
5. Conclusion:
Concludes with the key findings of the assessment.
Includes any dissenting opinions or additional considerations.
6. References and Appendices:
Lists the literature and data sources used in the assessment.
Provides detailed data and search results relevant to the toxicological evidence.
Request Information for this Addendum:
Hexyl Salicylate is used as a fragrance ingredient in various consumer goods, including cosmetics, and is not currently restricted under the EU Cosmetic Regulation.
RAC has proposed classifying Hexyl Salicylate as ‘Toxic for Reproduction Category 2’ and ‘Skin Sensitizer Category 1.’
Evaluations of related compounds, such as salicylic acid and methyl salicylate, have been conducted by SCCS.
A dossier was submitted claiming safe use for adults but lacking data for children under 3 years.
Further information was provided to address the safety of Hexyl Salicylate for children below 3 years.
The European Commission has requested SCCS to assess the safety of Hexyl Salicylate for young children and identify any additional scientific concerns.
Region: European Union
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert